{
    "nctId": "NCT05921617",
    "briefTitle": "A Cohort Study of Musculoskeletal Health in Patients With Breast Cancer During Aromatase Inhibitors Therapy",
    "officialTitle": "A Cohort Study of Musculoskeletal Health in Patients With Breast Cancer During Aromatase Inhibitors Therapy",
    "overallStatus": "RECRUITING",
    "conditions": "Musculoskeletal Health",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 870,
    "primaryOutcomeMeasure": "Changes in hand function",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Postoperative early breast cancer\uff1b\n2. Hormone receptor-positive breast cancer diagnosed by pathology\uff1b\n3. Aromatase inhibitor therapy (e.g., anastrozole, letrozole, exemestane) was initiated within 3 months;\n4. Postmenopausal women, or premenopausal or perimenopausal women taking ovarian function inhibitors;\n5. Informed consent and voluntary participation in the study.\n\nExclusion Criteria:\n\n1. Breast cancer recurrence or distant metastasis;\n2. With other malignant tumors;\n3. With cognitive or psychiatric disorders.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}